|
Generative AI Patient Education Module for Breast Oncology
RECRUITINGN/ASponsored by University of California, San Francisco
Actively Recruiting
PhaseN/A
SponsorUniversity of California, San Francisco
Started2026-07-14
Est. completion2027-01-31
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07512271
Summary
This study evaluates the safety, accuracy, and impact of an artificial intelligence (AI) tool designed to support patient education in breast cancer care for breast oncology patients under selected physicians care within the University of California, San Francisco breast cancer center and affiliate sites.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: 1. Females or males ages 18 and over. 2. Patients must have either: 1. Stage IV breast cancer facing a treatment change and are expected to have follow-up visits at least once every three months, or 2. Stage I-III breast cancer diagnosed within the past 6 months. 3. Basic computer literacy and regular internet access at home. 4. Able to understand study procedures and to comply with them for the entire length of the study. 5. Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it. Exclusion Criteria: 1. Contraindication to any study-related procedure or assessment. 2. Cognitive impairment that would interfere with tool usage or survey completion
Conditions4
Breast CancerCancerCarcinoma of the BreastMetastatic Breast Cancer
Locations1 site
University of California, San Francisco
Find trials near these locations
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorUniversity of California, San Francisco
Started2026-07-14
Est. completion2027-01-31
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07512271